CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.

Saved in:
Bibliographic Details
Title: CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.
Authors: Patil T; University of Colorado Cancer Center, Aurora, CO., Lin JJ; Massachusetts General Hospital, Boston, MA., Cheema PK; William Osler Health System, Calgary, Canada., Carrizosa DR; Levine Cancer Institute/Atrium Health, Charlotte, NC., Burkard ME; University of Iowa Health Care Holden Comprehensive Cancer Center, Iowa City, IA., Elamin YY; The University of Texas MD Anderson Cancer Center, Houston, TX., Desai J; Peter MacCallum Cancer Centre, Melbourne, Australia., Patel JD; Northwestern University, Chicago, IL., Nagasaka M; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA., Reckamp KL; Cedars-Sinai Medical Center, Los Angeles, CA., Waqar SN; Washington University School of Medicine, St Louis, MO., Bauman JR; Fox Chase Cancer Center, Philadelphia, PA., Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY., Gadgeel SM; Henry Ford Cancer Institute/Henry Ford Health System, Detroit, MI., Ma PC; Penn State Cancer Institute, Penn State University, Hershey, PA., Konduri K; Baylor Charles A. Sammons Cancer Center, Texas Oncology PA, Dallas, TX., Nguyen D; City of Hope, Huntington Beach, CA.; City of Hope, Irvine, CA., Misleh J; Medical Oncology Hematology Consultants, Newark, DE., Bleeker J; Sanford USD Medical Center, Sioux Falls, SD., Weiss M; ThedaCare Cancer Center, Appleton, WI., Thavaneswaran S; The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, Australia., Haura EB; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Deegan M; Elevation Oncology, Inc., Boston, MA., Kaufman J; Elevation Oncology, Inc., Boston, MA., Srivastava J; Elevation Oncology, Inc., Boston, MA., Jansen VM; Elevation Oncology, Inc., Boston, MA., Liu SV; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
Source: JCO precision oncology [JCO Precis Oncol] 2025 Aug; Vol. 9, pp. e2500221. Date of Electronic Publication: 2025 Dec 22.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-4284
DOI:10.1200/PO-25-00221